14 patents
Utility
IRAK4 Inhibitors and Topical Uses Thereof
7 Dec 23
This invention is directed to compositions including IRAK4 inhibitors useful for the treatment of dermatological disorders or conditions characterized by inflammation.
Jamie L. Harden, Delphine Imbert
Filed: 29 Jun 21
Utility
ROR gamma t Inhibitors and Topical Uses Thereof
12 Oct 23
The present disclosure is directed to use of RORγt inhibitors in the treatment of autoimmune disorders, e.g., autoimmune disorders of the skin.
Jamie L. Harden, Delphine Imbert
Filed: 29 Jun 21
Utility
Topical Compositions Comprising IRAK4 Inhibitors for Use in Treating Dermatological Conditions Characterised by Inflammation
27 Apr 23
This disclosure is directed to use of IRAK4 inhibitors in the treatment of dermatological disorders or conditions characterized by inflammation This disclosure is also directed to pharmaceutical compositions comprising an IRAK4 inhibitor and a pharmaceutically acceptable carrier for topical administration
Jamie L. Harden, Hans E.J. Hofland
Filed: 5 Nov 20
Utility
MrgprX2 Antagonists and Uses Thereof
26 Jan 23
The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin.
Ferda Cevikbas, Christopher Pearson, Donnya Etheridge, Laura Gleave, Mark Duggan, Nina Connelly Ursinyova, Vasileios Roumpelakis
Filed: 5 Nov 20
Utility
MrgprX2 Antagonists for the Treatment of Inflammatory Disorders
26 Jan 23
The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin.
Ferda Cevikbas, Ashley Jarvis, Laura Gleave, Nina Connelly Ursinyova, Ricky Cain, Wei Tsung Yau
Filed: 5 Nov 20
Utility
MrgprX2 Antagonists and Uses Thereof
5 Jan 23
The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin.
Ferda Cevikbas, Christopher Pearson, Laura Gleave, Nina Connelly Ursinyova
Filed: 5 Nov 20
Utility
ROR Gamma T Inhibitors and Topical Uses Thereof
29 Dec 22
The present disclosure is directed to use of RORγt inhibitors in the treatment of autoimmune disorders, e.g., autoimmune disorders of the skin.
Jamie L. Harden, Hans E.J. Hofland
Filed: 5 Nov 20
Utility
Processes for Making, and Methods of Using, Glycopyrronium Compounds
6 May 21
Provided herein are processes for making and methods of using salts of glycopyrronium, including solid forms and forms suitable for use as topicals.
Anthony Adrian SHAW
Filed: 8 Jan 21
Utility
Processes for making, and methods of using, glycopyrronium compounds
2 Feb 21
Provided herein are processes for making and methods of using salts of glycopyrronium, including solid forms and forms suitable for use as topicals.
Anthony Adrian Shaw
Filed: 1 Aug 17
Utility
Process for Production of Glycopyrronium Tosylate
6 Jan 21
Provided herein are methods for the production of glycopyrronium tosylate and glycopyrronium tosylate compositions.
Anthony Adrian SHAW, Enrico VIGANO, Renato MOLTENI
Filed: 20 Feb 20
Utility
Glycopyrrolate Salts
21 Oct 20
Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed.
John Allan STATLER, Anthony Adrian SHAW, Delphine Caroline IMBERT, Jennifer Leigh NELSON, Patricia ANDRES, Lisa Lynn McQUEEN, Stephan Xander Mattheus BOERRIGTER, Jon Gordon SELBO, Mark Christopher ANDRES
Filed: 29 Jun 20
Utility
Glycopyrrolate Salts
6 May 20
Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed.
John Allan STATLER, Anthony Adrian SHAW, Delphine Caroline IMBERT, Jennifer Leigh NELSON, Patricia ANDRES, Lisa Lynn McQUEEN, Stephan Xander Mattheus BOERRIGTER, Jon Gordon SELBO, Mark Christopher ANDRES
Filed: 7 Jan 20
Utility
Glycopyrrolate salts
3 Feb 20
Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed.
John Allan Statler, Anthony Adrian Shaw, Delphine Caroline Imbert, Jennifer Leigh Nelson, Patricia Andres, Lisa Lynn McQueen, Stephan Xander Mattheus Boerrigter, Jon Gordon Selbo, Mark Christopher Andres
Filed: 27 Dec 18
Utility
Glycopyrrolate salts
27 Jan 20
Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed.
John Allan Statler, Anthony Adrian Shaw, Delphine Caroline Imbert, Jennifer Leigh Nelson, Patricia Andres, Lisa Lynn McQueen, Stephan Xander Mattheus Boerrigter, Jon Gordon Selbo, Mark Christopher Andres
Filed: 31 May 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first